News Letter to Shareholders and Corporate Update Continue Reading Previous Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offeringNext Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Related Stories News Make Named Best AI Automation Platform for 2026 News Quick Custom Intelligence Brings Live, Next-Gen AI to ICE Barcelona 2026 with Modulus News Rent with Clara Launches Multi-Layer Bank Verification to Combat Rising Rental Application Fraud News Dash Social Launches New Publishing and Analytics Integration With Snap News AcuityTec Unveils Product Enhancements Strengthening KYT Intelligence and Global Data Risk Signals News Four Inc. Awarded NASPO ValuePoint® Cloud and Software Solutions Master Agreement
